RNA interference in the era of nucleic acid therapeutics

被引:98
作者
Jadhav, Vasant [1 ]
Vaishnaw, Akshay [1 ]
Fitzgerald, Kevin [1 ]
Maier, Martin A. [1 ]
机构
[1] Alnylam Pharmaceut, Res & Dev, Cambridge, MA 02142 USA
关键词
DOUBLE-STRANDED-RNA; MESSENGER-RNA; IN-VIVO; LIPID NANOPARTICLES; MAMMALIAN MICRORNAS; SYSTEMIC DELIVERY; CATIONIC LIPIDS; GENE; OLIGONUCLEOTIDE; CHOLESTEROL;
D O I
10.1038/s41587-023-02105-y
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Two decades of research on RNA interference (RNAi) have transformed a breakthrough discovery in biology into a robust platform for a new class of medicines that modulate mRNA expression. Here we provide an overview of the trajectory of small-interfering RNA (siRNA) drug development, including the first approval in 2018 of a liver-targeted siRNA interference (RNAi) therapeutic in lipid nanoparticles and subsequent approvals of five more RNAi drugs, which used metabolically stable siRNAs combined with N-acetylgalactosamine ligands for conjugate-based liver delivery. We also consider the remaining challenges in the field, such as delivery to muscle, brain and other extrahepatic organs. Today's RNAi therapeutics exhibit high specificity, potency and durability, and are transitioning from applications in rare diseases to widespread, chronic conditions. With six approved drugs, siRNA is now an established therapeutic modality poised for expansion.
引用
收藏
页码:394 / 405
页数:12
相关论文
共 141 条
[1]   Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides [J].
Ackermann, Elizabeth J. ;
Guo, Shuling ;
Benson, Merrill D. ;
Booten, Sheri ;
Freier, Sue ;
Hughes, Steven G. ;
Kim, Tae-Won ;
Kwoh, T. Jesse ;
Matson, John ;
Norris, Dan ;
Yu, Rosie ;
Watt, Andy ;
Monia, Brett P. .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2016, 23 (03) :148-157
[2]   Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis [J].
Adams, D. ;
Gonzalez-Duarte, A. ;
O'Riordan, W. D. ;
Yang, C. -C. ;
Ueda, M. ;
Kristen, A. V. ;
Tournev, I. ;
Schmidt, H. H. ;
Coelho, T. ;
Berk, J. L. ;
Lin, K. -P. ;
Vita, G. ;
Attarian, S. ;
Plante-Bordeneuve, V. ;
Mezei, M. M. ;
Campistol, J. M. ;
Buades, J. ;
Brannagan, T. H., III ;
Kim, B. J. ;
Oh, J. ;
Parman, Y. ;
Sekijima, Y. ;
Hawkins, P. N. ;
Solomon, S. D. ;
Polydefkis, M. ;
Dyck, P. J. ;
Gandhi, P. J. ;
Goyal, S. ;
Chen, J. ;
Strahs, A. L. ;
Nochur, S. V. ;
Sweetser, M. T. ;
Garg, P. P. ;
Vaishnaw, A. K. ;
Gollob, J. A. ;
Suhr, O. B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) :11-21
[3]   Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial [J].
Adams, David ;
Tournev, Ivailo L. ;
Taylor, Mark S. ;
Coelho, Teresa ;
Plante-Bordeneuve, Violaine ;
Berk, John L. ;
Gonzalez-Duarte, Alejandra ;
Gillmore, Julian D. ;
Low, Soon-Chai ;
Sekijima, Yoshiki ;
Obici, Laura ;
Chen, Chongshu ;
Badri, Prajakta ;
Arum, Seth M. ;
Vest, John ;
Polydefkis, Michael .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2023, 30 (01) :18-26
[4]   Pharmacokinetics and Pharmacodynamics of the Small Interfering Ribonucleic Acid, Givosiran, in Patients With Acute Hepatic Porphyria [J].
Agarwal, Sagar ;
Simon, Amy R. ;
Goel, Varun ;
Habtemariam, Bahru A. ;
Clausen, Valerie A. ;
Kim, Jae B. ;
Robbie, Gabriel J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (01) :63-72
[5]   Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms [J].
Akinc, Akin ;
Querbes, William ;
De, Soma ;
Qin, June ;
Frank-Kamenetsky, Maria ;
Jayaprakash, K. Narayanannair ;
Jayaraman, Muthusamy ;
Rajeev, Kallanthottathil G. ;
Cantley, William L. ;
Dorkin, J. Robert ;
Butler, James S. ;
Qin, LiuLiang ;
Racie, Timothy ;
Sprague, Andrew ;
Fava, Eugenio ;
Zeigerer, Anja ;
Hope, Michael J. ;
Zerial, Marino ;
Sah, Dinah W. Y. ;
Fitzgerald, Kevin ;
Tracy, Mark A. ;
Manoharan, Muthiah ;
Koteliansky, Victor ;
de Fougerolles, Antonin ;
Maier, Martin A. .
MOLECULAR THERAPY, 2010, 18 (07) :1357-1364
[6]   Development of Lipidoid-siRNA Formulations for Systemic Delivery to the Liver [J].
Akinc, Akin ;
Goldberg, Michael ;
Qin, June ;
Dorkin, J. Robert ;
Gamba-Vitalo, Christina ;
Maier, Martin ;
Jayaprakash, K. Narayanannair ;
Jayaraman, Muthusamy ;
Rajeev, Kallanthottathil G. ;
Manoharan, Muthiah ;
Koteliansky, Victor ;
Roehl, Ingo ;
Leshchiner, Elizaveta S. ;
Langer, Robert ;
Anderson, Daniel G. .
MOLECULAR THERAPY, 2009, 17 (05) :872-879
[7]   Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA [J].
Allerson, CR ;
Sioufi, N ;
Jarres, R ;
Prakash, TP ;
Naik, N ;
Berdeja, A ;
Wanders, L ;
Griffey, RH ;
Swayze, EE ;
Bhat, B .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (04) :901-904
[8]   A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system [J].
Alterman, Julia F. ;
Godinho, Bruno M. D. C. ;
Hassler, Matthew R. ;
Ferguson, Chantal M. ;
Echeverria, Dimas ;
Sapp, Ellen ;
Haraszti, Reka A. ;
Coles, Andrew H. ;
Conroy, Faith ;
Miller, Rachael ;
Roux, Loic ;
Yan, Paul ;
Knox, Emily G. ;
Turanov, Anton A. ;
King, Robert M. ;
Gernoux, Gwladys ;
Mueller, Christian ;
Gray-Edwards, Heather L. ;
Moser, Richard P. ;
Bishop, Nina C. ;
Jaber, Samer M. ;
Gounis, Matthew J. ;
Sena-Esteves, Miguel ;
Pai, Athma A. ;
DiFiglia, Marian ;
Aronin, Neil ;
Khvorova, Anastasia .
NATURE BIOTECHNOLOGY, 2019, 37 (08) :884-+
[9]   The impact of microRNAs on protein output [J].
Baek, Daehyun ;
Villen, Judit ;
Shin, Chanseok ;
Camargo, Fernando D. ;
Gygi, Steven P. ;
Bartel, David P. .
NATURE, 2008, 455 (7209) :64-U38
[10]   MODULATION OF MEMBRANE-FUSION BY ASYMMETRIC TRANSBILAYER DISTRIBUTIONS OF AMINO LIPIDS [J].
BAILEY, AL ;
CULLIS, PR .
BIOCHEMISTRY, 1994, 33 (42) :12573-12580